News

Our portfolio companies are making headlines by changing the life of patients. Stay up-to-date on their latest news.

Show articles

April, 25th

ACTICOR BIOTECH ANNOUNCES THAT THE EUROPEAN MEDICINES AGENCY CLEARS THE ROUTE FOR A PHASE II OF ITS ACT017 PRODUCT IN STROKE